NABHA Priorities and Initiatives
The NABHA Scientific Advisory Council counsels NMQF leadership on priority setting and the recommendation of educational strategies regarding appropriate regulatory policy to insure quality care.
During the 2020-2021 membership year, NABHA efforts addressed:
– Quality improvement initiatives associated with neuropsychiatric symptoms in dementia including agitation, psychosis, aggression, delusions, hallucinations, anxiety, depression, apathy, and mood disorders and stages of Alzheimer’s disease;
– Engagement on value assessment methodologies associated with major depressive disorder/clinical depression that can include persistently depressed mood, loss of interest in activities, and significant impairment in daily life; and
– Patient access, health policy, and regulations that compromise the quality of healthcare in long-term care settings.
In 2021-2022, NABHA priority efforts will continue to include:
– Quality improvement initiatives associated with neuropsychiatric symptoms in dementia including agitation, psychosis, aggression, delusions, hallucinations, anxiety, depression, apathy, mood disorders and stages of Alzheimer’s disease;
– Engagement on value assessment methodologies associated with major depressive disorder/clinical depression that can include persistently depressed mood, loss of interest in activities, and significant impairment in daily life; and
– Patient access, health policy, and regulations that compromise the quality of healthcare in long-term and other settings care.
New initiatives may include:
- Brain Injury (including Traumatic Brain Injury)
- Mood Disorders (including bi-polar disorder, depression, schizophrenia)
- Multiple Sclerosis
- Parkinson Disease
